Mycoplasma Testing Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Mycoplasma Testing Market in 2025 is estimated at USD 1.2 billion. The global Market size was valued at around USD 1.09 billion in 2024 and is projected to grow at a CAGR of more than 12.5%, reaching USD 5.04 billion revenue by 2037. North America is set to attain USD 1.86 billion by 2037, fueled by presence of biotech and pharmaceutical companies and increased investment in R&D for new drugs and therapies.
The market is growing owing to rising demand for biosimilars and biologics. The production of biologics and biosimilars requires the use of various raw materials, including cell culture media, growth factors, and additives. These materials are the potential source of mycoplasma contamination. In correspondence, mycoplasma testing becomes crucial to ensure the safer use of these raw materials.
Moreover, the rising globalization of clinical trials brings new opportunities for the mycoplasma testing market growth. The world is fostering research initiatives through international collaboration. This leads to the exchange of cell lines, samples, and reagents among countries and increases the risk of mycoplasma contamination. Thus, the test is used to preserve the integrity of shared material.
